Technology and functional insights into the nicotinamide mononucleotide for human health.
Biosynthesis
Healthy food
Nicotinamide mononucleotide
Physiological function
Journal
Applied microbiology and biotechnology
ISSN: 1432-0614
Titre abrégé: Appl Microbiol Biotechnol
Pays: Germany
ID NLM: 8406612
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
17
02
2023
accepted:
31
05
2023
revised:
26
05
2023
medline:
17
7
2023
pubmed:
22
6
2023
entrez:
22
6
2023
Statut:
ppublish
Résumé
Nicotinamide mononucleotide (NMN), a naturally occurring biologically active nucleotide, mainly functions via mediating the biosynthesis of NAD
Identifiants
pubmed: 37347262
doi: 10.1007/s00253-023-12612-2
pii: 10.1007/s00253-023-12612-2
doi:
Substances chimiques
Nicotinamide Mononucleotide
1094-61-7
NAD
0U46U6E8UK
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4759-4775Subventions
Organisme : National Key R & D Program of China
ID : No. 2021YFC2100900
Organisme : National Natural Science Foundation of China
ID : No. 32171261
Organisme : National Natural Science Foundation of China
ID : 21978116
Organisme : Fundamental Research Funds for the Central Universities
ID : No. JUSRP22047
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Alano CC, Ying W, Swanson RA (2004) Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem 279(18):18895–18902. https://doi.org/10.1074/jbc.M313329200
doi: 10.1074/jbc.M313329200
pubmed: 14960594
Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K, Haris M, Reddy R, Patay Z, Baur J, Bagga P (2021) Role of NAD(+) in regulating cellular and metabolic signaling pathways. Mol Metab 49:101195. https://doi.org/10.1016/j.molmet.2021.101195
doi: 10.1016/j.molmet.2021.101195
pubmed: 33609766
pmcid: 7973386
Assiri MA, Ali HR, Marentette JO, Yun Y, Liu J, Hirschey MD, Saba LM, Harris PS, Fritz KS (2019) Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. Hum Genomics 13(1):65. https://doi.org/10.1186/s40246-019-0251-1
doi: 10.1186/s40246-019-0251-1
pubmed: 31823815
pmcid: 6902345
Belenky P, Bogan KL, Brenner C (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32(1):12–19. https://doi.org/10.1016/j.tibs.2006.11.006
doi: 10.1016/j.tibs.2006.11.006
pubmed: 17161604
Bieganowski P, Brenner C (2004) Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117(4):495–502. https://doi.org/10.1016/S0092-8674(04)00416-7
doi: 10.1016/S0092-8674(04)00416-7
pubmed: 15137942
Black WB, Aspacio D, Bever D, King E, Zhang L, Li H (2020) Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor. Microb Cell Fact 19(1):150. https://doi.org/10.1186/s12934-020-01415-z
doi: 10.1186/s12934-020-01415-z
pubmed: 32718347
pmcid: 7384224
Bové J, Prou D, Perier C, Przedborski S (2005) Toxin-induced models of Parkinson’s disease. NeuroRx 2(3):484–494. https://doi.org/10.1602/neurorx.2.3.484
doi: 10.1602/neurorx.2.3.484
pubmed: 16389312
pmcid: 1144492
Brito S, Baek JM, Cha B, Heo H, Lee SH, Lei L, Jung SY, Lee SM, Lee SH, Kwak BM, Chae S, Lee MG, Bin BH (2022) Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling. J Dermatol Sci 106(3):159–169. https://doi.org/10.1016/j.jdermsci.2022.05.002
doi: 10.1016/j.jdermsci.2022.05.002
pubmed: 35610161
Caton PW, Kieswich J, Yaqoob MM, Holness MJ, Sugden MC (2011) Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function. Diabetologia 54(12):3083–3092. https://doi.org/10.1007/s00125-011-2288-0
doi: 10.1007/s00125-011-2288-0
pubmed: 21901281
Chandrasekaran K, Choi J, Arvas MI, Salimian M, Singh S, Xu S, Gullapalli RP, Kristian T, Russell JW (2020) Nicotinamide mononucleotide administration prevents experimental diabetes-induced cognitive impairment and loss of hippocampal neurons. Int J Mol Sci 21(11):3756. https://doi.org/10.3390/ijms21113756
doi: 10.3390/ijms21113756
pubmed: 32466541
pmcid: 7313029
Chen X, Amorim JA, Moustafa GA, Lee JJ, Yu Z, Ishihara K, Iesato Y, Barbisan P, Ueta T, Togka KA, Lu L, Sinclair DA, Vavvas DG (2020) Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment. Aging (Albany NY) 12(24):24504–24521. https://doi.org/10.18632/aging.202453
doi: 10.18632/aging.202453
pubmed: 33373320
Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021) NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol 22(2):119–141. https://doi.org/10.1038/s41580-020-00313-x
doi: 10.1038/s41580-020-00313-x
pubmed: 33353981
Cros C, Margier M, Cannelle H, Charmetant J, Hulo N, Laganier L, Grozio A, Canault M (2022) Nicotinamide mononucleotide administration triggers macrophages reprogramming and alleviates inflammation during sepsis induced by experimental peritonitis. Front Mol Biosci 9:895028. https://doi.org/10.3389/fmolb.2022.895028
doi: 10.3389/fmolb.2022.895028
pubmed: 35832733
pmcid: 9271973
de Picciotto NE, Gano LB, Johnson LC, Martens CR, Sindler AL, Mills KF, Imai S, Seals DR (2016) Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 15(3):522–530. https://doi.org/10.1111/acel.12461
doi: 10.1111/acel.12461
pubmed: 26970090
pmcid: 4854911
Fan H, Yang HC, You L, Wang YY, He WJ, Hao CM (2013) The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int 83(3):404–413. https://doi.org/10.1038/ki.2012.394
doi: 10.1038/ki.2012.394
pubmed: 23302720
Fu RZ, Zhang Q (2018a) Method for preparing nicotinamide mononucleotide (NMN). US Patent 0162895 A1
Fu RZ, Zhang Q (2018b) Nicotinamide phosphoribosyltransfrrase (NAMPT) mutant and use thereof. US Patent 0230443 A1
Gong JS, Zhang Q, Gu BC, Dong TT, Li H, Li H, Lu ZM, Shi JS, Xu ZH (2018) Efficient biocatalytic synthesis of nicotinic acid by recombinant nitrilase via high density culture. Bioresour Technol 260:427–431. https://doi.org/10.1016/j.biortech.2018.03.109
doi: 10.1016/j.biortech.2018.03.109
pubmed: 29655898
Guan Y, Wang SR, Huang XZ, Xie QH, Xu YY, Shang D, Hao CM (2017) Nicotinamide mononucleotide, an NAD(+) precursor, rescues age-associated susceptibility to AKI in a sirtuin 1-dependent manner. J Am Soc Nephrol 28(8):2337–2352. https://doi.org/10.1681/asn.2016040385
doi: 10.1681/asn.2016040385
pubmed: 28246130
pmcid: 5533221
He Z, Yang X, Tian X, Li L, Liu M (2022) Yeast cell surface engineering of a nicotinamide riboside kinase for the production of β-nicotinamide mononucleotide via whole-cell catalysis. ACS Synth Biol 11(10):3451–3459. https://doi.org/10.1021/acssynbio.2c00350
doi: 10.1021/acssynbio.2c00350
pubmed: 36219824
He JJ, Liu XX, Li Y, Wang Z, Shi HL, Kan YC, Yao LG, Tang CD (2023) High level expression of nicotinamide nucleoside kinase from Saccharomyces cerevisiae and its purification and immobilization by one-step method. Front Bioeng Biotechnol 11:1134152. https://doi.org/10.3389/fbioe.2023.1134152
doi: 10.3389/fbioe.2023.1134152
pubmed: 36873348
pmcid: 9975500
Hershberger KA, Martin AS, Hirschey MD (2017) Role of NAD(+) and mitochondrial sirtuins in cardiac and renal diseases. Nat Rev Nephrol 13(4):213–225. https://doi.org/10.1038/nrneph.2017.5
doi: 10.1038/nrneph.2017.5
pubmed: 28163307
pmcid: 5508210
Hong W, Mo F, Zhang Z, Huang M, Wei X (2020) Nicotinamide mononucleotide: a promising molecule for therapy of diverse diseases by targeting NAD+ metabolism. Front Cell Dev Biol 8:246. https://doi.org/10.3389/fcell.2020.00246
doi: 10.3389/fcell.2020.00246
pubmed: 32411700
pmcid: 7198709
Hosseini L, Vafaee MS, Badalzadeh R (2020) Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats. J Cardiovasc Pharmacol Ther 25(3):240–250. https://doi.org/10.1177/1074248419882002
doi: 10.1177/1074248419882002
pubmed: 31645107
Hroudova J, Singh N, Fisar Z (2014) Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer’s disease. Biomed Res Int 2014:175062. https://doi.org/10.1155/2014/175062
doi: 10.1155/2014/175062
pubmed: 24900954
pmcid: 4036420
Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, Shao D, Takagi H, Oka S, Sadoshima J (2010) Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 122(21):2170–2182. https://doi.org/10.1161/CIRCULATIONAHA.110.958033
doi: 10.1161/CIRCULATIONAHA.110.958033
pubmed: 21060073
pmcid: 3003297
Huang Z, Li N, Yu S, Zhang W, Zhang T, Zhou J (2022) Systematic engineering of Escherichia coli for efficient production of nicotinamide mononucleotide from nicotinamide. ACS Synth Biol 11(9):2979–2988. https://doi.org/10.1021/acssynbio.2c00100
doi: 10.1021/acssynbio.2c00100
pubmed: 35977419
In Ro B, Won Kang J, Min Kim S, Cheol Shin H (2020) Therapeutic effects of growth factor cocktail (CellcurinTM) containing FGF5s (fibroblast growth factor 5 short) and NMN (nicotinamide mononucleotide) in patients with androgenetic alopecia: a split study. Global Dermatol 7:1–5. https://doi.org/10.15761/god.1000229
Jafari-Azad A, Hosseini L, Rajabi M, Hoilund-Carlsen PF, Vafaee MS, Feyzizadeh S, Badalzadeh R (2021) Nicotinamide mononucleotide and melatonin counteract myocardial ischemia-reperfusion injury by activating SIRT3/FOXO1 and reducing apoptosis in aged male rats. Mol Biol Rep. https://doi.org/10.1007/s11033-021-06351-8
doi: 10.1007/s11033-021-06351-8
pubmed: 33866495
Jeck R, Heik P, Woenckhaus C (1974) Simple methods of preparing nicotinamide mononucleotide. FEBS Lett 42(2):161–164. https://doi.org/10.1016/0014-5793(74)80776-3
doi: 10.1016/0014-5793(74)80776-3
pubmed: 4369172
Jia Y, Kang X, Tan L, Ren Y, Qu L, Tang J, Liu G, Wang S, Xiong Z, Yang L (2021) Nicotinamide mononucleotide attenuates renal interstitial fibrosis after AKI by suppressing tubular DNA damage and senescence. Front Physiol 12:649547. https://doi.org/10.3389/fphys.2021.649547
doi: 10.3389/fphys.2021.649547
pubmed: 33833691
pmcid: 8021789
Kane AE, Sinclair DA (2018) Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res 123(7):868–885. https://doi.org/10.1161/CIRCRESAHA.118.312498
doi: 10.1161/CIRCRESAHA.118.312498
pubmed: 30355082
pmcid: 6206880
Katayoshi T, Nakajo T, Tsuji-Naito K (2021) Restoring NAD(+) by NAMPT is essential for the SIRT1/p53-mediated survival of UVA- and UVB-irradiated epidermal keratinocytes. J Photochem Photobiol B 221:112238. https://doi.org/10.1016/j.jphotobiol.2021.112238
doi: 10.1016/j.jphotobiol.2021.112238
pubmed: 34130091
Khan JA, Xiang S, Tong L (2007) Crystal structure of human nicotinamide riboside kinase. Structure 15(8):1005–1013. https://doi.org/10.1016/j.str.2007.06.017
doi: 10.1016/j.str.2007.06.017
pubmed: 17698003
Kim H-W, Ryoo G-H, Jang H-Y, Rah S-Y, Lee DH, Kim D-K, Bae EJ, Park B-H (2022) NAD
doi: 10.7150/thno.69684
pubmed: 35547746
pmcid: 9065190
Kiss T, Balasubramanian P, Valcarcel-Ares MN, Tarantini S, Yabluchanskiy A, Csipo T, Lipecz A, Reglodi D, Zhang XA, Bari F, Farkas E, Csiszar A, Ungvari Z (2019) Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment. GeroScience 41(5):619–630. https://doi.org/10.1007/s11357-019-00074-2
doi: 10.1007/s11357-019-00074-2
pubmed: 31144244
pmcid: 6885080
Kiss T, Giles CB, Tarantini S, Yabluchanskiy A, Balasubramanian P, Gautam T, Csipo T, Nyul-Toth A, Lipecz A, Szabo C, Farkas E, Wren JD, Csiszar A, Ungvari Z (2019) Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation and anti-atherogenic effects. Geroscience 41(4):419–439. https://doi.org/10.1007/s11357-019-00095-x
doi: 10.1007/s11357-019-00095-x
pubmed: 31463647
pmcid: 6815288
Kiss T, Nyul-Toth A, Balasubramanian P, Tarantini S, Ahire C, Yabluchanskiy A, Csipo T, Farkas E, Wren JD, Garman L, Csiszar A, Ungvari Z (2020) Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Geroscience 42(2):527–546. https://doi.org/10.1007/s11357-020-00165-5
doi: 10.1007/s11357-020-00165-5
pubmed: 32056076
pmcid: 7206476
Klimova N, Fearnow A, Long A, Kristian T (2020) NAD(+) precursor modulates post-ischemic mitochondrial fragmentation and reactive oxygen species generation via SIRT3 dependent mechanisms. Exp Neurol 325:113144. https://doi.org/10.1016/j.expneurol.2019.113144
doi: 10.1016/j.expneurol.2019.113144
pubmed: 31837320
Kong LH, Liu TY, Yao QS, Zhang XH, Xu WN, Qin JY (2023) Enhancing the biosynthesis of nicotinamide mononucleotide in Lactococcus lactis by heterologous expression of FtnadE. J Sci Food Agric 103(1):450–456. https://doi.org/10.1002/jsfa.12253
doi: 10.1002/jsfa.12253
pubmed: 36205212
Lee J, Churchil H, Choi WB, Lynch JE, Roberts FE, Volante RP, Reider PJ (1999) A chemical synthesis of nicotinamide adenine dinucleotide (NAD+). ChemComm 8:729–730. https://doi.org/10.1039/A809930H
doi: 10.1039/A809930H
Lee Y, Jeong H, Park KH, Kim KW (2020) Effects of NAD(+) in Caenorhabditis elegans models of neuronal damage. Biomolecules 10(7):993. https://doi.org/10.3390/biom10070993
Lee D, Tomita Y, Miwa Y, Jeong H, Shinojima A, Ban N, Yamaguchi S, Nishioka K, Negishi K, Yoshino J, Kurihara T (2022) Nicotinamide mononucleotide protects against retinal dysfunction in a murine model of carotid artery occlusion. Int J Mol Sci 23(23):14711. https://doi.org/10.3390/ijms232314711
Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M (2021) Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr 18(1):54. https://doi.org/10.1186/s12970-021-00442-4
doi: 10.1186/s12970-021-00442-4
pubmed: 34238308
pmcid: 8265078
Lin JB, Kubota S, Ban N, Yoshida M, Santeford A, Sene A, Nakamura R, Zapata N, Kubota M, Tsubota K, Yoshino J, Imai SI, Apte RS (2016) NAMPT-mediated NAD(+) biosynthesis is essential for vision in mice. Cell Rep 17(1):69–85. https://doi.org/10.1016/j.celrep.2016.08.073
doi: 10.1016/j.celrep.2016.08.073
pubmed: 27681422
pmcid: 5104206
Lin Q, Zuo W, Liu Y, Wu K, Liu Q (2021) NAD(+) and cardiovascular diseases. Clin Chim Acta 515:104–110. https://doi.org/10.1016/j.cca.2021.01.012
doi: 10.1016/j.cca.2021.01.012
pubmed: 33485900
Liu J, Zong Z, Zhang W, Chen Y, Wang X, Shen J, Yang C, Liu X, Deng H (2021) Nicotinamide mononucleotide alleviates LPS-induced inflammation and oxidative stress via decreasing COX-2 expression in macrophages. Front Mol Biosci 8:702107. https://doi.org/10.3389/fmolb.2021.702107
doi: 10.3389/fmolb.2021.702107
pubmed: 34295923
pmcid: 8290259
Liu Y, Yasawong M, Yu B (2021) Metabolic engineering of Escherichia coli for biosynthesis of β-nicotinamide mononucleotide from nicotinamide. Microb Biotechnol. https://doi.org/10.1111/1751-7915.13901
doi: 10.1111/1751-7915.13901
pubmed: 34843635
pmcid: 8966003
Long AN, Owens K, Schlappal AE, Kristian T, Fishman PS, Schuh RA (2015) Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer’s disease-relevant murine model. BMC Neurol 15:19. https://doi.org/10.1186/s12883-015-0272-x
doi: 10.1186/s12883-015-0272-x
pubmed: 25884176
pmcid: 4358858
Lu L, Tang L, Wei W, Hong Y, Chen H, Ying W, Chen S (2014) Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease. Exp Ther Med 8(3):943–950. https://doi.org/10.3892/etm.2014.1842
doi: 10.3892/etm.2014.1842
pubmed: 25120628
pmcid: 4113526
Maharjan A, Singhvi M, Kim BS (2021) Biosynthesis of a therapeutically important nicotinamide mononucleotide through a phosphoribosyl pyrophosphate synthetase 1 and 2 engineered strain of Escherichia coli. ACS Synth Biol 10(11):3055–3065. https://doi.org/10.1021/acssynbio.1c00333
doi: 10.1021/acssynbio.1c00333
pubmed: 34747173
Majeed Y, Halabi N, Madani AY, Engelke R, Bhagwat AM, Abdesselem H, Agha MV, Vakayil M, Courjaret R, Goswami N, Hamidane HB, Elrayess MA, Rafii A, Graumann J, Schmidt F, Mazloum NA (2021) SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways. Sci Rep 11(1):8177. https://doi.org/10.1038/s41598-021-87759-x
doi: 10.1038/s41598-021-87759-x
pubmed: 33854178
pmcid: 8046990
Marinescu GC, Popescu RG, Stoian G, Dinischiotu A (2018) beta-Nicotinamide mononucleotide (NMN) production in Escherichia coli. Sci Rep 8(1):12278. https://doi.org/10.1038/s41598-018-30792-0
doi: 10.1038/s41598-018-30792-0
pubmed: 30115969
pmcid: 6095924
Meng YF, Pu Q, Dai SY, Ma Q, Li X, Zhu W (2021) Nicotinamide mononucleotide alleviates hyperosmolarity-induced IL-17a secretion and macrophage activation in corneal epithelial cells/macrophage co-culture system. J Inflamm Res 14:479–493. https://doi.org/10.2147/JIR.S292764
doi: 10.2147/JIR.S292764
pubmed: 33658825
pmcid: 7917392
Miao Y, Cui Z, Gao Q, Rui R, Xiong B (2020) Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep 32(5):107987. https://doi.org/10.1016/j.celrep.2020.107987
doi: 10.1016/j.celrep.2020.107987
pubmed: 32755581
Mikhailopulo IA, Pricota TI, Timoshchuk VA (1981) Akhrem AA (1981) Synthesis of glycosides of nicotinamide and nicotinamide mononucleotide. Synthesis 05:388–389. https://doi.org/10.1055/s-1981-29462
doi: 10.1055/s-1981-29462
Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, Yoshino J, Imai SI (2016) Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab 24(6):795–806. https://doi.org/10.1016/j.cmet.2016.09.013
doi: 10.1016/j.cmet.2016.09.013
pubmed: 28068222
pmcid: 5668137
Morris MJ, Beilharz JE, Maniam J, Reichelt AC, Westbrook RF (2015) Why is obesity such a problem in the 21st century? The intersection of palatable food, cues and reward pathways, stress, and cognition. Neurosci Biobehav Rev 58:36–45. https://doi.org/10.1016/j.neubiorev.2014.12.002
doi: 10.1016/j.neubiorev.2014.12.002
pubmed: 25496905
Petriti B, Williams PA, Lascaratos G, Chau KY, Garway-Heath DF (2021) Neuroprotection in glaucoma: NAD(+)/NADH redox state as a potential biomarker and therapeutic target. Cells 10(6):1402. https://doi.org/10.3390/cells10061402
Poddar SK, Sifat AE, Haque S, Nahid NA, Chowdhury S, Mehedi I (2019) Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules 9(1):34. https://doi.org/10.3390/biom9010034
Preiss J, Handler P (1957) Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 225:759–770. https://doi.org/10.1016/S0021-9258(18)64875-6
doi: 10.1016/S0021-9258(18)64875-6
pubmed: 13416279
Qian X-L, Dai Y-S, Li C-X, Pan J, Xu J-H, Mu B (2022) Enzymatic synthesis of high-titer nicotinamide mononucleotide with a new nicotinamide riboside kinase and an efficient ATP regeneration system. Bioresour Bioprocess 9(1):26. https://doi.org/10.1186/s40643-022-00514-6
Rajabi M, Vafaee MS, Hosseini L, Badalzadeh R (2022) Pretreatment with nicotinamide mononucleotide increases the effect of ischaemic postconditioning on cardioprotection and mitochondrial function following ex vivo myocardial reperfusion injury in aged rats. Clin Exp Pharmacol Physiol 49(4):474–482. https://doi.org/10.1111/1440-1681.13616
doi: 10.1111/1440-1681.13616
pubmed: 34854121
Ratajczak J, Joffraud M, Trammell SA, Ras R, Canela N, Boutant M, Kulkarni SS, Rodrigues M, Redpath P, Migaud ME, Auwerx J, Yanes O, Brenner C, Canto C (2016) NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun 7:13103. https://doi.org/10.1038/ncomms13103
doi: 10.1038/ncomms13103
pubmed: 27725675
pmcid: 5476803
Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, Milbrandt J, Kiess W, Imai S (2007) Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6(5):363–375. https://doi.org/10.1016/j.cmet.2007.09.003
doi: 10.1016/j.cmet.2007.09.003
pubmed: 17983582
pmcid: 2098698
Ru M, Wang W, Zhai Z, Wang R, Li Y, Liang J, Kothari D, Niu K, Wu X (2022) Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells. Food Funct 13(14):7507–7519. https://doi.org/10.1039/d2fo00525e
doi: 10.1039/d2fo00525e
pubmed: 35678708
Sanada S, Komuro I, Kitakaze M (2011) Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 301(5):H1723–H1741. https://doi.org/10.1152/ajpheart.00553.2011
doi: 10.1152/ajpheart.00553.2011
pubmed: 21856909
Sauve A, Mohammed FSY (2020) Efficient synthesis of nicotinamide mononucleotide. US Patent 0216487 A1
Schondorf DC, Ivanyuk D, Baden P, Sanchez-Martinez A, De Cicco S, Yu C, Giunta I, Schwarz LK, Di Napoli G, Panagiotakopoulou V, Nestel S, Keatinge M, Pruszak J, Bandmann O, Heimrich B, Gasser T, Whitworth AJ, Deleidi M (2018) The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease. Cell Rep 23(10):2976–2988. https://doi.org/10.1016/j.celrep.2018.05.009
doi: 10.1016/j.celrep.2018.05.009
pubmed: 29874584
Shang Y-T, Qin J, Gong J-S, Wang Z-K, Li H, Li H, Shi J-S, Xu Z-H (2021) High-throughput screening of a nicotinate dehydrogenase producing Pseudomonas putida mutant for efficient biosynthesis of 6-hydroxynicotinic acid. Mol Catal 509:111600. https://doi.org/10.1016/j.mcat.2021.111600
Shen Q, Zhang SJ, Xue YZ, Peng F, Cheng DY, Xue YP, Zheng YG (2021) Biological synthesis of nicotinamide mononucleotide. Biotechnol Lett 43(12):2199–2208. https://doi.org/10.1007/s10529-021-03191-1
doi: 10.1007/s10529-021-03191-1
pubmed: 34626279
Shoji S, Yamaji T, Makino H, Ishii J, Kondo A (2020) Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide. Metab Eng 65:167–177. https://doi.org/10.1016/j.ymben.2020.11.008
doi: 10.1016/j.ymben.2020.11.008
pubmed: 33220420
Sinclair DA, Ear PH (2016) Bological production of nad precursors and analogs. US Patent 0287621 A1
Sonntag T, Ancel S, Karaz S, Cichosz P, Jacot G, Giner MP, Sanchez-Garcia JL, Pannerec A, Moco S, Sorrentino V, Canto C, Feige JN (2022) Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration. Front Cell Dev Biol 10:1049653. https://doi.org/10.3389/fcell.2022.1049653
doi: 10.3389/fcell.2022.1049653
pubmed: 36438552
pmcid: 9682158
Sugiyama K, Iijima K, Yoshino M, Dohra H, Tokimoto Y, Nishikawa K, Idogaki H, Yoshida N (2021) Nicotinamide mononucleotide production by fructophilic lactic acid bacteria. Sci Rep 11(1):7662. https://doi.org/10.1038/s41598-021-87361-1
doi: 10.1038/s41598-021-87361-1
pubmed: 33828213
pmcid: 8027369
Tanimori S, Ohta T, Kirihata M (2002) An efficient chemical synthesis of nicotinamide riboside (NAR) and analogues. Bioorg Med Chem 12(8):1135–1137. https://doi.org/10.1016/S0960-894X(02)00125-7
doi: 10.1016/S0960-894X(02)00125-7
Tarantini S, Valcarcel-Ares MN, Toth P, Yabluchanskiy A, Tucsek Z, Kiss T, Hertelendy P, Kinter M, Ballabh P, Sule Z, Farkas E, Baur JA, Sinclair DA, Csiszar A, Ungvari Z (2019) Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox Biol 24:101192. https://doi.org/10.1016/j.redox.2019.101192
doi: 10.1016/j.redox.2019.101192
pubmed: 31015147
pmcid: 6477631
Tian Y, Zhu CL, Li P, Li HR, Liu Q, Deng XM, Wang JF (2023) Nicotinamide mononucleotide attenuates LPS-induced acute lung injury with anti-inflammatory, anti-oxidative and anti-apoptotic effects. J Surg Res 283:9–18. https://doi.org/10.1016/j.jss.2022.09.030
doi: 10.1016/j.jss.2022.09.030
pubmed: 36347171
Walt DR, Findeis MA, Rios-Mercadillo VM, Auge J, Whitesides GM (2002) An efficient chemical and enzymic synthesis of nicotinamide adenine dinucleotide (NAD+). J A Chem Soc 106(1):234–239. https://doi.org/10.1021/ja00313a045
doi: 10.1021/ja00313a045
Wang X, Hu X, Yang Y, Takata T, Sakurai T (2016) Nicotinamide mononucleotide protects against beta-amyloid oligomer-induced cognitive impairment and neuronal death. Brain Res 1643:1–9. https://doi.org/10.1016/j.brainres.2016.04.060
doi: 10.1016/j.brainres.2016.04.060
pubmed: 27130898
Wang ZK, Gong JS, Qin J, Li H, Lu ZM, Shi JS, Xu ZH (2021) Improving the intensity of integrated expression for microbial production. ACS Synth Biol 10(11):2796–2807. https://doi.org/10.1021/acssynbio.1c00334
doi: 10.1021/acssynbio.1c00334
pubmed: 34738786
Wu L, Sinclair DA, Meetze K (2018) Enzymatic systems and methods for synthesizing nicotinamide mononucleotide and nicotinic acid mononucleotide. US Patent 0163243 A1
Yamamoto T, Byun J, Zhai P, Ikeda Y, Oka S, Sadoshima J (2014) Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion. PLoS One 9(6):e98972. https://doi.org/10.1371/journal.pone.0098972
doi: 10.1371/journal.pone.0098972
pubmed: 24905194
pmcid: 4048236
Yao Z, Yang W, Gao Z, Jia P (2017) Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease. Neurosci Lett 647:133–140. https://doi.org/10.1016/j.neulet.2017.03.027
doi: 10.1016/j.neulet.2017.03.027
pubmed: 28330719
Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V (2023) The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience 45(1):29–43. https://doi.org/10.1007/s11357-022-00705-1
doi: 10.1007/s11357-022-00705-1
pubmed: 36482258
Yoshino J, Mills KF, Yoon MJ, Imai S (2011) Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14(4):528–536. https://doi.org/10.1016/j.cmet.2011.08.014
doi: 10.1016/j.cmet.2011.08.014
pubmed: 21982712
pmcid: 3204926
Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, Sindelar M, Pietka T, Patterson BW, Imai S-I, Klein S (2021) Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372(6547):1224–1229. https://doi.org/10.1126/science.abe9985
doi: 10.1126/science.abe9985
pubmed: 33888596
pmcid: 8550608
Zhan T, Xiong H, Pang J, Zhang W, Ye Y, Liang Z, Huang X, He F, Jian B, He W, Gao Y, Min X, Zheng Y, Yang H (2021) Modulation of NAD(+) biosynthesis activates SIRT1 and resists cisplatin-induced ototoxicity. Toxicol Lett 349:115–123. https://doi.org/10.1016/j.toxlet.2021.05.013
doi: 10.1016/j.toxlet.2021.05.013
pubmed: 34089817
Zhang YS, Gong JS, Yao ZY, Jiang JY, Su C, Li H, Kang CL, Liu L, Xu ZH, Shi JS (2022) Insights into the source, mechanism and biotechnological applications of hyaluronidases. Biotechnol Adv 60:108018. https://doi.org/10.1016/j.biotechadv.2022.108018
doi: 10.1016/j.biotechadv.2022.108018
pubmed: 35853550
Zhang Y, Zhu W, Wang M, Xi P, Wang H, Tian D (2023) Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet. IUBMB Life. https://doi.org/10.1002/iub.2707
doi: 10.1002/iub.2707
pubmed: 37310057
Zhou C, Feng J, Wang J, Hao N, Wang X, Chen K (2022) Design of an in vitro multienzyme cascade system for the biosynthesis of nicotinamide mononucleotide. Catal Sci Technol 12(4):1080–1091. https://doi.org/10.1039/d1cy01798e
doi: 10.1039/d1cy01798e
Zong Z, Liu J, Wang N, Yang C, Wang Q, Zhang W, Chen Y, Liu X, Deng H (2021) Nicotinamide mononucleotide inhibits hepatic stellate cell activation to prevent liver fibrosis via promoting PGE2 degradation. Free Radic Biol Med 162:571–581. https://doi.org/10.1016/j.freeradbiomed.2020.11.014
doi: 10.1016/j.freeradbiomed.2020.11.014
pubmed: 33220424
Zou XD, Guo SQ, Hu ZW, Li WL (2016) NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity. Mol Med Rep 13(5):4058–4064. https://doi.org/10.3892/mmr.2016.5034
doi: 10.3892/mmr.2016.5034
pubmed: 27035562